[1]
Nahmias, Z.P., Merrill, E.D., Briscoe, C.C., Mount, C.E., Abner, S., Schaffer, A. and Anadkat, M.J. 2018. Development of Bullous Pemphigoid While Receiving PD-1 Checkpoint Inhibitor Nivolumab. SKIN The Journal of Cutaneous Medicine. 2, 3 (Apr. 2018), 175–180. DOI:https://doi.org/10.25251/skin.2.3.5.